BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33148675)

  • 1. Discrimination of Breast Cancer from Healthy Breast Tissue Using a Three-component Diffusion-weighted MRI Model.
    Andreassen MMS; Rodríguez-Soto AE; Conlin CC; Vidić I; Seibert TM; Wallace AM; Zare S; Kuperman J; Abudu B; Ahn GS; Hahn M; Jerome NP; Østlie A; Bathen TF; Ojeda-Fournier H; Goa PE; Rakow-Penner R; Dale AM
    Clin Cancer Res; 2021 Feb; 27(4):1094-1104. PubMed ID: 33148675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
    Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
    World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
    Tezcan S; Ozturk FU; Uslu N; Akcay EY
    Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and Diagnostic Performance of Voxelwise Computed Diffusion-Weighted Imaging in Breast Cancer.
    Zhou J; Chen E; Xu H; Ye Q; Li J; Ye S; Cheng Q; Zhao L; Su MY; Wang M
    J Magn Reson Imaging; 2019 Jun; 49(6):1610-1616. PubMed ID: 30328211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.
    Ei Khouli RH; Jacobs MA; Mezban SD; Huang P; Kamel IR; Macura KJ; Bluemke DA
    Radiology; 2010 Jul; 256(1):64-73. PubMed ID: 20574085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
    Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
    Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
    Liu C; Liang C; Liu Z; Zhang S; Huang B
    Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).
    Rahbar H; Zhang Z; Chenevert TL; Romanoff J; Kitsch AE; Hanna LG; Harvey SM; Moy L; DeMartini WB; Dogan B; Yang WT; Wang LC; Joe BN; Oh KY; Neal CH; McDonald ES; Schnall MD; Lehman CD; Comstock CE; Partridge SC
    Clin Cancer Res; 2019 Mar; 25(6):1756-1765. PubMed ID: 30647080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution diffusion-weighted imaging compared with conventional diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging with regard to image quality and assessment of breast cancer morphology.
    Metin Y; Orhan Metin N; Kul S; Taşçı F; Özdemir O; Küpeli A
    Diagn Interv Radiol; 2023 Mar; 29(2):251-259. PubMed ID: 36987843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer.
    Ha SM; Chang JM; Lee SH; Kim ES; Kim SY; Cho N; Moon WK
    Breast Cancer Res Treat; 2020 Jul; 182(2):283-297. PubMed ID: 32447596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
    McDonald ES; Romanoff J; Rahbar H; Kitsch AE; Harvey SM; Whisenant JG; Yankeelov TE; Moy L; DeMartini WB; Dogan BE; Yang WT; Wang LC; Joe BN; Wilmes LJ; Hylton NM; Oh KY; Tudorica LA; Neal CH; Malyarenko DI; Comstock CE; Schnall MD; Chenevert TL; Partridge SC
    Radiology; 2021 Jan; 298(1):60-70. PubMed ID: 33201788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted imaging: determination of the best pair of b-values to discriminate breast lesions.
    Nogueira L; Brandão S; Matos E; Nunes RG; Loureiro J; Ferreira HA; Ramos I
    Br J Radiol; 2014 Jul; 87(1039):20130807. PubMed ID: 24834475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.
    Yang X; Dong M; Li S; Chai R; Zhang Z; Li N; Zhang L
    Eur Radiol; 2020 Sep; 30(9):4795-4805. PubMed ID: 32350660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
    Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
    Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast MRI in the era of diffusion weighted imaging: do we still need signal-intensity time curves?
    Dietzel M; Ellmann S; Schulz-Wendtland R; Clauser P; Wenkel E; Uder M; Baltzer PAT
    Eur Radiol; 2020 Jan; 30(1):47-56. PubMed ID: 31359125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of malignant and benign breast lesions: Added value of the qualitative analysis of breast lesions on diffusion-weighted imaging (DWI) using readout-segmented echo-planar imaging at 3.0 T.
    An YY; Kim SH; Kang BJ
    PLoS One; 2017; 12(3):e0174681. PubMed ID: 28358833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.